Hallenbeck, John M.
National Institutes of Health · National Institute of Neurological Disorders and Stroke
4 papers on CoChat
Most cited papers
- Verified
The many faces of tumor necrosis factor in stroke
Hallenbeck, J. M. (2002) · Nature Medicine
Neuroinflammation and Neurodegeneration MechanismsAcute Ischemic Stroke Management
Cited by 367
- Verified
Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation
Peruzzotti-Jametti, L., Bernstock, J. D., Vicario, N., Costa, A. S. H., Kwok, C. K., Leonardi, T., Booty, L. M., Bicci, I., Balzarotti, B., Volpe, G., et al. (2018) · Cell Stem Cell
Neuroinflammation and Neurodegeneration MechanismsNeurogenesis and neuroplasticity mechanisms
Cited by 285
- Verified
Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells
Lee, Y.-J., Miyake, S.-I., Wakita, H., McMullen, D. C., Azuma, Y., Auh, S., & Hallenbeck, J. M. (2007) · Journal of Cerebral Blood Flow & Metabolism
Ubiquitin and proteasome pathwaysCardiac Ischemia and Reperfusion
Cited by 202
- Verified
Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming
Bernstock, J. D., Ye, D., Gessler, F. A., Lee, Y.-J., Peruzzotti-Jametti, L., Baumgarten, P., Johnson, K. R., Maric, D., Yang, W., Kögel, D., et al. (2017) · Scientific Reports
Ubiquitin and proteasome pathwaysGlioma Diagnosis and Treatment
Cited by 46
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free